We are driving advancements in human health by providing a high-quality portfolio of services that can be used individually or as an end-to-end solution to accelerate your drug candidates to clinical trials. We pioneered the use of our RNAi technologies for the development of custom mouse and rat models for critical in vivo studies. We empower researchers to gain precise control over in vivo gene expression by designing precise, translatable, genetically-engineered animal and cellular models with potent, reversible gene silencing.
Customize RNAi and CRISPR/Cas9 mouse and rat models with potent, reversible gene silencing for drug discovery and target validation.
Learn More
Recreate the architecture and physiology of human organs with clinically relevant 3D tissue cultures developed from induced pluripotent stem cells (iPSCs).
Learn More
Therapeutic developers partner with Mirimus to accelerate their end-to-end preclinical study pipelines.
Learn More
